Zeitschriftenaufsatz
|
2013
Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.
Autor:in
Wressnigg, Nina; Pöllabauer, Eva-Maria; Aichinger, Gerald; Portsmouth, Daniel; Löw-Baselli, Alexandra; Fritsch, Sandor; Livey, Ian; Crowe, Brian A; Schwendinger, Michael; Brühl, Peter; Pilz, Andreas; Dvorak, Thomas; Singer, Julia; Firth, Clair; Luft, Benjamin; Schmitt, Bernhard; Zeitlinger, Markus; Müller, Markus; Kollaritsch, Herwig; Paulke-Korinek, Maria; Esen, Meral; Kremsner, Peter G; Ehrlich, Hartmut J; Barrett, P Noel;
Publikationen als Autor:in / Herausgeber:in der Vetmeduni
Journal
Schlagwörter
Adjuvants, Immunologic/adverse effects*; Adult; Antigens, Surface/adverse effects*; Antigens, Surface/immunology*; Bacterial Outer Membrane Proteins/adverse effects*; Bacterial Outer Membrane Proteins/immunology*; Bacterial Vaccines/adverse effects*; Bacterial Vaccines/immunology*; Borrelia burgdorferi/immunology*; Double-Blind Method; Female; Headache/chemically induced; Humans; Immunoglobulin G/blood; Lipoproteins/adverse effects*; Lipoproteins/immunology*; Lyme Disease Vaccines/adverse effects*; Lyme Disease Vaccines/immunology*; Male; Middle Aged; Pain/chemically induced; Young Adult;
Dokumententyp
Originalarbeit
ISSN/eISSN
1473-3099 -
10.1016/S1473-3099(13)70110-5
WoS ID
PubMed ID